Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-23

Clinical Trial Update: A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports completion of a study evaluating Elaprase (idursulfase) in children and adults with Hunter syndrome in India, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elaprase (idursulfase)

Snippet

Sponsor: Takeda | Conditions: Hunter Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2025-01-23